Note: The 2012, 2013 publications have not been audited.
Jump to: Publications | Grants and Consultancies | HDR completions
2012 School of Medicine
Khasraw, Mutsafa, Bell, Richard and Dang, Chau (2012) Epirubicin : is it like doxorubicin in breast cancer? A clinical review, Breast, vol. 21, no. 2, pp. 142-149, Churchill Livingstone, Kidlington, England [C1]
ERA journal ID: 15822 – Scopus EID: Not tagged
Citation counts:Thomson - 4
DRO entry for this publication
2012 External
Khasraw, Mustafa and Bell, Richard* (2012) Primary systemic therapy in HER2-amplified breast cancer : a clinical review, Expert review of anticancer therapy, vol. 12, no. 8, pp. 1005-1013, Expert Reviews, London, England [C1]
ERA journal ID: 16124 – Scopus EID: Not taggedDRO entry for this publication
2011 External
Noor, Suzita M., Bell, Richard* and Ward, Alister C. (2011) Shooting the messenger : targeting signal transduction pathways in leukemia and related disorders, Critical reviews in oncology / hematology, vol. 78, no. 1, pp. 33-44, Elsevier Ireland Ltd, Clare, Ireland [C1]
ERA journal ID: 15974 – Scopus EID: 2-s2.0-79952361856DRO entry for this publication
2008 External
Keele, Sophie M* and Bell, Richard C* (2008) The factorial validity of emotional intelligence : an unresolved issue, Journal of personality and individual differences, vol. 44, no. 2, pp. 487-500, Elservier Ltd., Amsterdam, The Netherlands [C1.1]
ERA journal ID: 6553 – Scopus EID: 2-s2.0-36248937782
Citation counts:Scopus - 22,
Thomson - 22
DRO entry for this publication
2006 External
Darbyshire, Penny*, Bell, Richard* and McDonald, Heath (2006) Testing the circumplex model of emotions in a consumer setting, in Ali, Yunus and van Dessel, Maria (eds), ANZMAC 2006 : Advancing theory, maintaining relevance, proceedings, Queensland University of Technology, School of Advertising, Marketing and Public Relations, Brisbane, Qld. [E1]
DRO entry for this publication
All years
Research Income - Industry and Other Funding - International A (Competitive, Peer-Reviewed Research Grant Income)
Ward, A and Bell, R*. CONTACT: Consortium for the evaluation of targered cancer therapies [V.2]
- 2009: $192,049
- 2010: $88,555
No completions found or audited.
DRO to publications collection last synchronised: Wednesday 22nd May 2013 10:04pm